| 51433-1 |
Renin^pre or post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Renin [Mass/volume] in Plasma --pre or post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/L;pg/mL |
|
|
|
|
|
|
CHAL |
|
51433-1 |
|
|
|
|
Observation |
|
|
|
0 |
Renin pre/p chal Plas-mCnc |
|
|
|
N |
|
After; Angiotensin forming enzyme; Angiotensinogenase; Before; Cardio; Cardiology; CHEMISTRY.CHALLENGE TESTING; Direct renin; DRC; Endocrine; Endocrinology; Heart Disease; Kidney; Level; Mass concentration; Nephrology; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; Renal |
2.7 |
2.22 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 51434-9 |
Somatotropin^pre or post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --pre or post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
51434-9 |
|
|
|
|
Observation |
|
|
|
0 |
GH pre/p chal SerPl-mCnc |
|
|
|
N |
|
After; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.73 |
2.22 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 51435-6 |
Protein.monoclonal band 1 |
MCnc |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
51435-6 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
M Protein 1 SerPl Elph-mCnc |
|
|
|
N |
|
Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; i; Level; M Protein; M Protein 1; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR |
2.73 |
2.22 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 51436-4 |
Protein.monoclonal |
MCnc |
Urine |
24H |
Qn |
Electrophoresis |
|
ACTIVE |
Protein.monoclonal [Mass/volume] in 24 hour Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
51436-4 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
M Protein 24h Ur Elph-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Kidney; Level; M Protein; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; PEUR; PR; Prot; QNT; Quan; Quant; Quantitative; Renal; UA; UPEP; UR; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 51437-2 |
Protein.monoclonal band 2 |
MCnc |
Urine |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Protein.monoclonal band 2 [Mass/volume] in Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
51437-2 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
M Protein 2 Ur Elph-mCnc |
|
|
|
N |
|
Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; II; Kidney; Level; M Protein; M Protein 2; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UPEP; UR; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 51438-0 |
Protein.monoclonal band 2 |
MCnc |
Urine |
24H |
Qn |
Electrophoresis |
|
ACTIVE |
Protein.monoclonal band 2 [Mass/volume] in 24 hour Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
51438-0 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
M Protein 2 24h Ur Elph-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; II; Kidney; Level; M Protein; M Protein 2; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; PEUR; PR; Prot; QNT; Quan; Quant; Quantitative; Renal; UA; UPEP; UR; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 51439-8 |
Protein.monoclonal band 3 |
MCnc |
Urine |
24H |
Qn |
Electrophoresis |
|
ACTIVE |
Protein.monoclonal band 3 [Mass/volume] in 24 hour Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
51439-8 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
M Protein 3 24h Ur Elph-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; AE1 Anion Exchanger; Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; III; Kidney; Level; M Protein; M Protein 3; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; PEUR; PR; Prot; QNT; Quan; Quant; Quantitative; Renal; UA; UPEP; UR; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 5144-1 |
Echovirus 6 Ab.Neut |
Titr |
Ser |
Pt |
SemiQn |
Neut |
|
ACTIVE |
Echovirus 6 neutralizing antibody [Titer] in Serum by Neutralization test |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
5144-1 |
|
Neut |
|
|
Both |
|
|
|
0 |
ECV6 NAb Titr Ser Nt |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; Echovirus type 6; ECV; ECV6; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; |
0 |
| 51440-6 |
Protein.monoclonal band 3 |
MCnc |
Urine |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Protein.monoclonal band 3 [Mass/volume] in Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
51440-6 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
M Protein 3 Ur Elph-mCnc |
|
|
|
N |
|
AE1 Anion Exchanger; Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; III; Kidney; Level; M Protein; M Protein 3; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UPEP; UR; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 51441-4 |
Macroprolactin/Prolactin |
MFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Macroprolactin/Prolactin [Mass] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
51441-4 |
|
|
|
|
Both |
|
|
|
0 |
Macroprolactin/Prolactin MFr SerPl |
|
|
|
N |
|
bbPRL; Big-big prolactin; Chemistry; IgG-bound Prolactin; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.22 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 51442-2 |
Domperidone |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Domperidone [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
51442-2 |
|
|
|
|
Both |
|
|
|
0 |
Domperidone SerPl-sCnc |
|
|
|
N |
|
Costi; DRUG/TOXICOLOGY; Drugs; Level; Motilium; Motillium; Motinorm; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.22 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 51443-0 |
Cells.CD117 |
ACnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD117 cells [Units/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
0-514 cells/cmm |
|
|
|
|
|
CELLMARK |
|
51443-0 |
|
|
|
|
Both |
|
|
|
0 |
CD117 Cells Bld-aCnc |
|
|
|
N |
|
Arbitrary concentration; Blood; CD117 Cells; Cell; CELL MARKERS; Cellularity; c-KIT; Point in time; QNT; Quan; Quant; Quantitative; Random; SCFR; stem cell factor receptor; WB; Whole blood |
2.7 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 51444-8 |
Cells.CD19+CD38+ |
ACnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD19+CD38+ cells [Units/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
0-350 |
|
|
|
|
|
CELLMARK |
|
51444-8 |
|
|
|
|
Both |
|
|
|
0 |
CD19+CD38+ Cells Bld-aCnc |
|
|
|
N |
|
ADP-ribosyl cyclase; Arbitrary concentration; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD38+ Cells; Cell; CELL MARKERS; Cellularity; Cyclic ADP-ribose hydrolase; HD-37; Leu12; Leu-12; Leu17; Leu-17; Point in time; QNT; Quan; Quant; Quantitative; Random; T10; WB; Whole blood |
2.7 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 51445-5 |
Cells.CD41a |
ACnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD41a cells [Units/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
0-2900 |
|
|
|
|
|
CELLMARK |
|
51445-5 |
|
|
|
|
Both |
|
|
|
0 |
CD41a Cells Bld-aCnc |
|
|
|
N |
|
Arbitrary concentration; Blood; CD41a Cells; Cell; CELL MARKERS; Cellularity; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 51446-3 |
Cells.CD64 |
ACnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD64 cells [Units/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
1100-3200 |
|
|
|
|
|
CELLMARK |
|
51446-3 |
|
|
|
|
Both |
|
|
|
0 |
CD64 Cells Bld-aCnc |
|
|
|
N |
|
Arbitrary concentration; Blood; CD64 Cells; Cell; CELL MARKERS; Cellularity; Fc gamma receptor I; Fc gamma RI; FC gammaRI; FCR I; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 51447-1 |
Cells.CD79a |
ACnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
CD79a cells [Units/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
0-380 |
|
|
|
|
|
CELLMARK |
|
51447-1 |
|
|
|
|
Both |
|
|
|
0 |
CD79a Cells Bld-aCnc |
|
|
|
N |
|
Arbitrary concentration; Blood; CD79a Cells; Cell; CELL MARKERS; Cellularity; Ig alpha; MB1; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 51448-9 |
Dihydrocodeine+Hydrocodol |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Dihydrocodeine+Hydrocodol [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
0-100 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
51448-9 |
|
|
|
|
Both |
|
|
|
0 |
DHC+hydrocodol Ur-mCnc |
|
|
|
N |
|
DF-118; DHC; DHC+hydrocodol; DHCPlus; Drocode; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 51449-7 |
Paragonimus sp Ab |
Titr |
Ser |
Pt |
SemiQn |
IA |
|
ACTIVE |
Paragonimus sp Ab [Titer] in Serum by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
titer |
"<1:32" |
|
|
|
|
|
MICRO |
|
51449-7 |
|
IA |
|
|
Both |
|
|
|
0 |
Paragonimus Ab Titr Ser IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Random; Serum; SmQn; species; spp; SR; SUDS; Titer; Titered; Titre; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 5145-8 |
Echovirus 6 Ab |
Titr |
Ser |
Pt |
SemiQn |
Comp fix |
|
ACTIVE |
Echovirus 6 Ab [Titer] in Serum by Complement fixation |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
5145-8 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
ECV6 Ab Titr Ser CF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; Echovirus type 6; ECV; ECV6; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 51450-5 |
Paragonimus sp Ab |
Titr |
Plr fld |
Pt |
SemiQn |
IA |
|
ACTIVE |
Paragonimus sp Ab [Titer] in Pleural fluid by Immunoassay |
|
MAJ |
DefinitionDescription |
|
|
titer |
"<1:32" |
|
|
|
|
|
MICRO |
|
51450-5 |
|
IA |
|
|
Both |
|
|
|
0 |
Paragonimus Ab Titr Plr IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lung; MEIA; Microbiology; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; Random; Respiratory; SmQn; species; spp; SUDS; thoracentesis fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 51451-3 |
Bartonella quintana Ab.IgG |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51451-3 |
|
|
|
|
Both |
|
|
|
0 |
B quintana IgG SerPl-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B quintana; Cat Scratch Disease; Cat Scratch Fever; CSD; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; R quintana; Random; Rochalimae quintana; Rochalimaea quintana; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trench fever |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 51452-1 |
Coccidioides immitis Ab |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Coccidioides immitis Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
51452-1 |
|
|
|
|
Both |
|
|
|
0 |
C immitis Ab Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; B/F; BF; Blastomycoides immitis; bod; Bodies; Body fluid; Body fluid, unsp; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Infectious Disease; InfectiousDisease; Microbiology; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; Pseudococcidioides mazzai; Random; San Joaquin Valley fever; SmQn; T proteolyticum; Titer; Titered; Titre; Trichosporon proteolyticum; Ttr; Valley fever |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 51453-9 |
Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
51453-9 |
|
|
|
|
Both |
|
|
|
0 |
CV A9+B1-6 Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A9; CV A9+B1-6; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 51454-7 |
Epstein Barr virus early diffuse Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Epstein Barr virus early diffuse Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51454-7 |
|
|
|
|
Both |
|
|
|
0 |
EBV EA-D Ab CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EA; EA-D; EBV; EBV EA; EBV EA-D; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.56 |
2.22 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 51455-4 |
Filaria Ab.IgG1 |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Filaria IgG1 Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51455-4 |
|
|
|
|
Both |
|
|
|
0 |
Filaria IgG1 Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Filarial; Filariasis; ID; IgG 1; IgG subgroup 1; Infectious Disease; InfectiousDisease; Microbiology; Microfilaria; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
